| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2001 | WO2001036629A1 Transfer compounds, the production and the use thereof |
| 05/25/2001 | WO2001036628A1 Methods of reversing drug resistance in cancer cells |
| 05/25/2001 | WO2001036627A2 Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036625A2 ANTISENSE OLIGONUCLEOTIDE SEQUENCES DERIVED FROM groEL AND groES AS INHIBITORS MICROORGANISMS |
| 05/25/2001 | WO2001036624A1 High order nucleic acid based structures |
| 05/25/2001 | WO2001036623A2 Ecdysone-inducible adeno-associated virus expression vectors |
| 05/25/2001 | WO2001036621A2 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 05/25/2001 | WO2001036620A2 Vectors and transgenies with regulatory elements for gene delivery to the liver |
| 05/25/2001 | WO2001036619A2 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/25/2001 | WO2001036617A2 Assay for measuring enzyme activity in vivo |
| 05/25/2001 | WO2001036616A2 Acid nucleic construct bearing a system regulating the expression of a gene |
| 05/25/2001 | WO2001036615A2 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 05/25/2001 | WO2001036614A2 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036607A1 Site-directed mutagenesis of escherichia coli phytase |
| 05/25/2001 | WO2001036606A2 Protoporphyrinogen ix oxidase and the use thereof |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036603A2 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036601A1 Method for the preparation of purified hcv rna by exosome separation |
| 05/25/2001 | WO2001036600A1 MOUSE ASPARTIC SECRETASE-2 (mASP-2) |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036598A1 Environmental stress tolerance genes |
| 05/25/2001 | WO2001036597A1 Plant biochemistry-related genes |
| 05/25/2001 | WO2001036596A2 Modulation of plant response to abscisic acid |
| 05/25/2001 | WO2001036595A2 Methods for conditional transgene expression and trait removal in plants |
| 05/25/2001 | WO2001036589A2 Human ex vivo immune system |
| 05/25/2001 | WO2001036586A2 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 05/25/2001 | WO2001036583A1 Continuous-flow method for preparing microparticles |
| 05/25/2001 | WO2001036489A2 Erythropoietin forms with improved properties |
| 05/25/2001 | WO2001036488A1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036486A2 Scfv antibodies against disease associated molecules |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036483A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 05/25/2001 | WO2001036482A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | WO2001036480A1 Mouse 7-transmembrane receptor, axor45 |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036473A2 Human g protein-coupled receptors |
| 05/25/2001 | WO2001036471A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036467A2 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | WO2001036464A2 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 05/25/2001 | WO2001036463A2 Genes specifically expressed in human dendritic cells |
| 05/25/2001 | WO2001036462A2 Protein c derivatives |
| 05/25/2001 | WO2001036460A2 Methods and means for regulation of gene expression |
| 05/25/2001 | WO2001036458A2 Drosophila ced-6 homologue |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036446A2 Use of g-protein coupled receptors (gpcrs) and modified gpcrs for the treatment of diseases |
| 05/25/2001 | WO2001036444A1 Plant developmental genes |
| 05/25/2001 | WO2001036443A1 Antisense modulation of nck-2 expression |
| 05/25/2001 | WO2001036441A1 Antisense modulation of src-3 expression |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036005A2 Targeted delivery of therapeutic and diagnostic moieties |
| 05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
| 05/25/2001 | WO2001035995A2 Tr3-specific binding agents and methods for their use |
| 05/25/2001 | WO2001035991A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 05/25/2001 | WO2001035985A1 P-superfamily conopeptides |
| 05/25/2001 | WO2001035980A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 05/25/2001 | WO2001035750A1 Methods for using lactonohydrolases in baking |
| 05/25/2001 | WO2001035735A1 Production of ungulates, preferably bovines that produce human immunoglobulins |
| 05/25/2001 | WO2001035734A1 An improved method for production of porcine clone embryos via somatic cell nuclear transfer |
| 05/25/2001 | WO2001035733A1 Method of acquiring immunological tolerance |
| 05/25/2001 | WO2001035732A1 An animal model for studying hormone signalling and method of modulating the signalling |
| 05/25/2001 | WO2001035727A1 Seed trait genes |
| 05/25/2001 | WO2001035726A1 Pathogen tolerance genes |
| 05/25/2001 | WO2001035725A1 Yield-related genes |
| 05/25/2001 | WO2001012235A3 Targeted artificial gene delivery |
| 05/25/2001 | WO2001011008A3 Process for obtaining and detecting gram-positive fluorescent bacteria |
| 05/25/2001 | WO2001007159A3 Integration of biochemical protocols in a continuous flow microfluidic device |
| 05/25/2001 | WO2001006005A3 Diagnostic method comprising wt1 sequences |
| 05/25/2001 | WO2001004314A3 Nucleic acid molecules and proteins associated with sterol synthesis and metabolism |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2000078956A8 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000075190A3 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO2000061814A8 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 05/25/2001 | WO2000047750B1 Metalloproteases of the neprilysin family |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | WO1997013866A3 Recombinant herpes virus vectors for expression in neuronal cells |
| 05/25/2001 | CA2732120A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392109A1 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392094A1 Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |